Desferal and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Desferal (deferoxamine mesylate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Exjade, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Drowsiness when taking Desferal. It is created by eHealthMe based on reports of 2,241 people who have side effects when taking Desferal from the FDA, and is updated regularly.

What is Desferal?

Desferal has active ingredients of deferoxamine mesylate. It is often used in iron overload. eHealthMe is studying from 2,248 Desferal users. Check the latest studies of Desferal.

What is Drowsiness?

Drowsiness is found to be associated with 2,867 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 29, 2026

2,241 people reported to have side effects when taking Desferal.
Among them, 20 people (0.89%) have Drowsiness.

Among these 20 people:

How long have people been on Desferal when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Desferal? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Drowsiness when taking Desferal? *

What are other drugs people take besides Desferal? *

What are other side effects people have besides Drowsiness? *

Diarrhea: 11 people, 55.00%
Nausea And Vomiting: 10 people, 50.00%
Renal Impairment (severely reduced kidney function): 10 people, 50.00%
Urination - Painful: 10 people, 50.00%
Dizziness: 10 people, 50.00%
Drug Ineffective: 9 people, 45.00%
Itching: 9 people, 45.00%
Weakness: 9 people, 45.00%
Haemoglobin Decreased: 9 people, 45.00%
Serum Ferritin Increased: 9 people, 45.00%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 8 people, 40.00%
Secondary Hypothyroidism (pituitary gland and its failure to secrete tsh): 2 people, 10.00%
Pain: 2 people, 10.00%
Haemochromatosis (body to absorb more iron than usual from food): 2 people, 10.00%
Cardiomyopathy (weakening of the heart muscle): 2 people, 10.00%
Neuralgia (pain in one or more nerves): 1 person, 5.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.00%
Liver Disorder (liver diseases): 1 person, 5.00%
Diabetes: 1 person, 5.00%
Asthma: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Desferal and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Desferal:

Desferal (2,248 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Desferal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,867 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on deferoxamine mesylate (the active ingredients of Desferal) and Desferal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.